vs
Esperion Therapeutics, Inc.（ESPR）与Priority Technology Holdings, Inc.（PRTH）财务数据对比。点击上方公司名可切换其他公司
Priority Technology Holdings, Inc.的季度营收约是Esperion Therapeutics, Inc.的1.5倍（$247.1M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 8.8%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs 9.6%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
Priority Technology Holdings, Inc.是一家聚焦信息技术领域的企业，业务围绕计算机、通信系统等相关信息设备展开，涵盖信息的创建、处理、存储、检索与传输等相关信息技术应用服务，依托计算机科学与工程技术支撑业务开展。
ESPR vs PRTH — 直观对比
营收规模更大
PRTH
是对方的1.5倍
$168.4M
营收增速更快
ESPR
高出134.9%
8.8%
两年增速更快
ESPR
近两年复合增速
9.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $247.1M |
| 净利润 | — | $8.9M |
| 毛利率 | — | — |
| 营业利润率 | 50.6% | 13.6% |
| 净利率 | — | 3.6% |
| 营收同比 | 143.7% | 8.8% |
| 净利润同比 | — | 23.9% |
| 每股收益（稀释后） | $0.32 | $0.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRPRTH
| Q4 25 | $168.4M | $247.1M | ||
| Q3 25 | $87.3M | $241.4M | ||
| Q2 25 | $82.4M | $239.8M | ||
| Q1 25 | $65.0M | $224.6M | ||
| Q4 24 | $69.1M | $227.1M | ||
| Q3 24 | $51.6M | $227.0M | ||
| Q2 24 | $73.8M | $219.9M | ||
| Q1 24 | $137.7M | $205.7M |
净利润ESPRPRTH
| Q4 25 | — | $8.9M | ||
| Q3 25 | $-31.3M | $27.6M | ||
| Q2 25 | $-12.7M | $10.9M | ||
| Q1 25 | $-40.5M | $8.3M | ||
| Q4 24 | — | $7.2M | ||
| Q3 24 | $-29.5M | $10.6M | ||
| Q2 24 | $-61.9M | $994.0K | ||
| Q1 24 | $61.0M | $5.2M |
营业利润率ESPRPRTH
| Q4 25 | 50.6% | 13.6% | ||
| Q3 25 | -11.4% | 15.6% | ||
| Q2 25 | 8.6% | 15.6% | ||
| Q1 25 | -34.0% | 14.5% | ||
| Q4 24 | -6.4% | 15.0% | ||
| Q3 24 | -31.0% | 16.8% | ||
| Q2 24 | 3.5% | 15.1% | ||
| Q1 24 | 52.5% | 13.6% |
净利率ESPRPRTH
| Q4 25 | — | 3.6% | ||
| Q3 25 | -35.9% | 11.4% | ||
| Q2 25 | -15.4% | 4.5% | ||
| Q1 25 | -62.2% | 3.7% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | -57.2% | 4.7% | ||
| Q2 24 | -83.9% | 0.5% | ||
| Q1 24 | 44.3% | 2.5% |
每股收益（稀释后）ESPRPRTH
| Q4 25 | $0.32 | $0.10 | ||
| Q3 25 | $-0.16 | $0.34 | ||
| Q2 25 | $-0.06 | $0.14 | ||
| Q1 25 | $-0.21 | $0.10 | ||
| Q4 24 | $-0.14 | $-0.05 | ||
| Q3 24 | $-0.15 | $0.07 | ||
| Q2 24 | $-0.33 | $-0.23 | ||
| Q1 24 | $0.34 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $77.2M |
| 总债务越低越好 | — | $1.0B |
| 股东权益账面价值 | $-302.0M | $-100.4M |
| 总资产 | $465.9M | $2.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ESPRPRTH
| Q4 25 | $167.9M | $77.2M | ||
| Q3 25 | $92.4M | $57.0M | ||
| Q2 25 | $86.1M | $50.6M | ||
| Q1 25 | $114.6M | $47.6M | ||
| Q4 24 | $144.8M | $58.6M | ||
| Q3 24 | $144.7M | $41.1M | ||
| Q2 24 | $189.3M | $34.6M | ||
| Q1 24 | $226.6M | $34.3M |
总债务ESPRPRTH
| Q4 25 | — | $1.0B | ||
| Q3 25 | — | $997.5M | ||
| Q2 25 | — | $917.0M | ||
| Q1 25 | — | $918.9M | ||
| Q4 24 | — | $920.9M | ||
| Q3 24 | — | $808.1M | ||
| Q2 24 | — | $809.0M | ||
| Q1 24 | — | $631.4M |
股东权益ESPRPRTH
| Q4 25 | $-302.0M | $-100.4M | ||
| Q3 25 | $-451.4M | $-110.3M | ||
| Q2 25 | $-433.5M | $-146.1M | ||
| Q1 25 | $-426.2M | $-158.3M | ||
| Q4 24 | $-388.7M | $-166.8M | ||
| Q3 24 | $-370.2M | $-165.8M | ||
| Q2 24 | $-344.2M | $-172.1M | ||
| Q1 24 | $-294.3M | $-159.9M |
总资产ESPRPRTH
| Q4 25 | $465.9M | $2.4B | ||
| Q3 25 | $364.0M | $2.2B | ||
| Q2 25 | $347.1M | $2.0B | ||
| Q1 25 | $324.0M | $1.9B | ||
| Q4 24 | $343.8M | $1.8B | ||
| Q3 24 | $314.1M | $1.8B | ||
| Q2 24 | $352.3M | $1.7B | ||
| Q1 24 | $373.1M | $1.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $36.8M |
| 自由现金流经营现金流 - 资本支出 | — | $30.9M |
| 自由现金流率自由现金流/营收 | — | 12.5% |
| 资本支出强度资本支出/营收 | 0.0% | 2.4% |
| 现金转化率经营现金流/净利润 | — | 4.12× |
| 过去12个月自由现金流最近4个季度 | — | $75.1M |
8季度趋势，按日历期对齐
经营现金流ESPRPRTH
| Q4 25 | $45.2M | $36.8M | ||
| Q3 25 | $-4.3M | $36.1M | ||
| Q2 25 | $-31.4M | $17.1M | ||
| Q1 25 | $-22.6M | $10.0M | ||
| Q4 24 | $-35.0M | $23.8M | ||
| Q3 24 | $-35.3M | $19.8M | ||
| Q2 24 | $-7.2M | $28.7M | ||
| Q1 24 | $53.8M | $13.3M |
自由现金流ESPRPRTH
| Q4 25 | — | $30.9M | ||
| Q3 25 | — | $30.1M | ||
| Q2 25 | — | $9.2M | ||
| Q1 25 | — | $4.9M | ||
| Q4 24 | — | $19.1M | ||
| Q3 24 | $-35.5M | $14.5M | ||
| Q2 24 | $-7.3M | $23.6M | ||
| Q1 24 | $53.8M | $6.7M |
自由现金流率ESPRPRTH
| Q4 25 | — | 12.5% | ||
| Q3 25 | — | 12.5% | ||
| Q2 25 | — | 3.8% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 8.4% | ||
| Q3 24 | -68.7% | 6.4% | ||
| Q2 24 | -9.9% | 10.7% | ||
| Q1 24 | 39.0% | 3.3% |
资本支出强度ESPRPRTH
| Q4 25 | 0.0% | 2.4% | ||
| Q3 25 | 0.0% | 2.5% | ||
| Q2 25 | 0.0% | 3.3% | ||
| Q1 25 | 0.0% | 2.3% | ||
| Q4 24 | 0.0% | 2.0% | ||
| Q3 24 | 0.3% | 2.3% | ||
| Q2 24 | 0.1% | 2.3% | ||
| Q1 24 | 0.1% | 3.2% |
现金转化率ESPRPRTH
| Q4 25 | — | 4.12× | ||
| Q3 25 | — | 1.31× | ||
| Q2 25 | — | 1.57× | ||
| Q1 25 | — | 1.20× | ||
| Q4 24 | — | 3.29× | ||
| Q3 24 | — | 1.87× | ||
| Q2 24 | — | 28.87× | ||
| Q1 24 | 0.88× | 2.56× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
PRTH
暂无分部数据
